VLC
BMY icon

Van Leeuwen & Company’s Bristol-Myers Squibb BMY Stock Holding History

Van Leeuwen & Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.82M Sell
52,025
-9,908
-16% -$505K 1.43% 23
2023
Q4 		$3.18M Sell
61,933
-18,087
-23% -$949K 1.85% 15
2023
Q3 		$4.64M Buy
80,020
+20
+0% +$1.23K 2.89% 11
2023
Q2 		$5.15M Sell
80,000
-2,575
-3% -$173K 3.23% 10
2023
Q1 		$5.72M Sell
82,575
-870
-1% -$61.4K 3.84% 6
2022
Q4 		$6M Sell
83,445
-577
-0.7% -$43.5K 4.15% 4
2022
Q3 		$5.97M Sell
84,022
-329
-0.4% -$23.9K 4.76% 6
2022
Q2 		$6.5M Buy
84,351
+81,136
+2,524% +$6.18M 5.44% 4
2022
Q1 		$235K Sell
3,215
-89,366
-97% -$6M 0.17% 61
2021
Q4 		$5.77M Sell
92,581
-2,225
-2% -$131K 3.24% 9
2021
Q3 		$5.61M Buy
94,806
+90
+0.1% +$5.93K 3.44% 8
2021
Q2 		$6.3M Buy
94,716
+44,838
+90% +$2.92M 3.73% 7
2021
Q1 		$3.15M Buy
49,878
+10,331
+26% +$643K 2.07% 18
2020
Q4 		$2.44M Sell
39,547
-51,510
-57% -$3.17M 1.64% 24
2020
Q3 		$5.49M Buy
91,057
+51,823
+132% +$3.12M 4.27% 4
2020
Q2 		$2.31M Buy
39,234
+2,822
+8% +$169K 1.79% 23
2020
Q1 		$2.03M Buy
36,412
+264
+0.7% +$16.1K 1.95% 19
2019
Q4 		$2.32M Buy
36,148
+16,781
+87% +$961K 1.93% 18
2019
Q3 		$982K Sell
19,367
-33,477
-63% -$1.57M 0.93% 43
2019
Q2 		$2.4M Buy
+52,844
New +$2.46M 2.15% 13

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Van Leeuwen & Company's BMY Position: Q1 2024 in Review

Van Leeuwen & Company reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q1 2024, selling an estimated $505K and leaving 52,025 shares worth $2.82M. The position accounts for 1.43% of the portfolio, ranked #23.

Van Leeuwen & Company first reported a position in BMY in Q2 2019 and has held it in 20 quarters since. The position peaked at $6.5M in Q2 2022. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Van Leeuwen & Company held 52,025 shares of Bristol-Myers Squibb worth $2.82M as of Q1 2024.
  • Van Leeuwen & Company sold 9,908 Bristol-Myers Squibb shares in Q1 2024, an estimated $505K.
  • Bristol-Myers Squibb made up 1.43% of Van Leeuwen & Company's portfolio in Q1 2024, its #23 holding.
  • Van Leeuwen & Company first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 20 quarters since.
  • Van Leeuwen & Company's Bristol-Myers Squibb position peaked at $6.5M in Q2 2022.
  • 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Van Leeuwen & Company's 13F filing for Q1 2024, filed 10 May 2024.